
Suzanne E. Mcdowell
Examiner (ID: 243)
| Most Active Art Unit | 1732 |
| Art Unit(s) | 1732, 1307, 1791 |
| Total Applications | 702 |
| Issued Applications | 527 |
| Pending Applications | 59 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7089038
[patent_doc_number] => 20050009151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods for the stereospecific and enantiomeric enrichment of beta-amino acids'
[patent_app_type] => utility
[patent_app_number] => 10/875161
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22130
[patent_no_of_claims] => 138
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10875161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/875161 | Methods for the stereospecific and enantiomeric enrichment of beta-amino acids | Jun 21, 2004 | Abandoned |
Array
(
[id] => 7402692
[patent_doc_number] => 20040226502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase'
[patent_app_type] => new
[patent_app_number] => 10/478284
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 163894
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20040226502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478284 | Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase | Jun 13, 2004 | Abandoned |
Array
(
[id] => 7419001
[patent_doc_number] => 20040228852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Use of increased molecular-weight hirudin as an anticoagulant in extracorporeal kidney replace therapy'
[patent_app_type] => new
[patent_app_number] => 10/850701
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850701 | Use of increased molecular-weight hirudin as an anticoagulant in extracorporeal kidney replace therapy | May 20, 2004 | Abandoned |
Array
(
[id] => 7295991
[patent_doc_number] => 20040214219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Nucleotide sequences which code for the tal gene'
[patent_app_type] => new
[patent_app_number] => 10/847610
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5978
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847610
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847610 | Process for the preparation of L-amino acids by overexpressing the tal gene encoding transaldolase | May 17, 2004 | Issued |
Array
(
[id] => 7225398
[patent_doc_number] => 20050255112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Compositions and methods for preventing erythropoietin-associated hypertension'
[patent_app_type] => utility
[patent_app_number] => 10/848689
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10786
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848689
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848689 | Compositions and methods for preventing erythropoietin-associated hypertension | May 16, 2004 | Abandoned |
Array
(
[id] => 7426774
[patent_doc_number] => 20040265809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications'
[patent_app_type] => new
[patent_app_number] => 10/477116
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 81384
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477116 | Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications | May 3, 2004 | Abandoned |
Array
(
[id] => 277876
[patent_doc_number] => 07556950
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-07-07
[patent_title] => 'Crystallization of the catalytic domain of human phosphodiesterase 4-D3 (PDE4-D3)'
[patent_app_type] => utility
[patent_app_number] => 10/836040
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7025
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/556/07556950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10836040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/836040 | Crystallization of the catalytic domain of human phosphodiesterase 4-D3 (PDE4-D3) | Apr 28, 2004 | Issued |
Array
(
[id] => 928607
[patent_doc_number] => 07314917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-01
[patent_title] => 'Modified vitamin K-dependent polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/828901
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 26
[patent_no_of_words] => 20279
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828901
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828901 | Modified vitamin K-dependent polypeptides | Apr 20, 2004 | Issued |
Array
(
[id] => 5205733
[patent_doc_number] => 20070027215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Nuclear receptor ligands and ligand binding domains'
[patent_app_type] => utility
[patent_app_number] => 10/827121
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 34739
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827121 | Nuclear receptor ligands and ligand binding domains | Apr 15, 2004 | Abandoned |
Array
(
[id] => 5655863
[patent_doc_number] => 20060141599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Crystals of Glucokinase and methods of growing them'
[patent_app_type] => utility
[patent_app_number] => 10/816708
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 5964
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816708 | Crystals of glucokinase and methods of growing them | Apr 1, 2004 | Issued |
Array
(
[id] => 7296268
[patent_doc_number] => 20040214294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Process for the production of L-amino acids using strains of the enterobacteriaceae family'
[patent_app_type] => new
[patent_app_number] => 10/812315
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6671
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10812315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/812315 | Process for the production of L-amino acids using strains of the enterobacteriaceae family | Mar 29, 2004 | Abandoned |
Array
(
[id] => 5040678
[patent_doc_number] => 20070092960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems'
[patent_app_type] => utility
[patent_app_number] => 10/548403
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11751
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548403 | Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5921553
[patent_doc_number] => 20060240080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Alginate sponge and preparation method thereof'
[patent_app_type] => utility
[patent_app_number] => 10/549002
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2382
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549002 | Alginate sponge and preparation method thereof | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7422042
[patent_doc_number] => 20040229255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Nucleotide sequence coding for the OtsA protein'
[patent_app_type] => new
[patent_app_number] => 10/801847
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8875
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801847 | Nucleotide sequence coding for the OtsA protein | Mar 16, 2004 | Abandoned |
Array
(
[id] => 256232
[patent_doc_number] => 07575905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Process for L-amino acid production using enterobacteriaceae strains with enhanced yibD'
[patent_app_type] => utility
[patent_app_number] => 10/794417
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/575/07575905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794417 | Process for L-amino acid production using enterobacteriaceae strains with enhanced yibD | Mar 7, 2004 | Issued |
Array
(
[id] => 281643
[patent_doc_number] => 07553642
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Branched neutral amino acid transporters acting as single molecule'
[patent_app_type] => utility
[patent_app_number] => 10/547975
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 11202
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553642.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547975 | Branched neutral amino acid transporters acting as single molecule | Mar 4, 2004 | Issued |
Array
(
[id] => 5650401
[patent_doc_number] => 20060136136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Crystal structure of baff, and use thereof in drug design'
[patent_app_type] => utility
[patent_app_number] => 10/794755
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 162
[patent_figures_cnt] => 162
[patent_no_of_words] => 19617
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20060136136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794755 | Crystal structure of baff, and use thereof in drug design | Mar 4, 2004 | Abandoned |
Array
(
[id] => 5787076
[patent_doc_number] => 20060205933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same'
[patent_app_type] => utility
[patent_app_number] => 10/547771
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 34582
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547771 | Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same | Mar 3, 2004 | Issued |
Array
(
[id] => 7252231
[patent_doc_number] => 20040259176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity'
[patent_app_type] => new
[patent_app_number] => 10/785823
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 576
[patent_figures_cnt] => 576
[patent_no_of_words] => 12587
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10785823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785823 | Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity | Feb 23, 2004 | Abandoned |
Array
(
[id] => 7127341
[patent_doc_number] => 20050059085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/783206
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23876
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783206 | Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof | Feb 19, 2004 | Abandoned |